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The impact of residual recombination centers after low-energy self-implantation of crystalline
silicon wafers and annealing at 900 °C has been determined by bulk carrier lifetime measurements
as a function of implant dose. Doses below 1013 cm−2 resulted in no measurable increase in
recombination, while higher doses caused a linear increase in the recombination center density. This
threshold value corresponds to the known critical dose required for the formation of relatively stable
dislocation loops during high temperature annealing. Deep level transient spectroscopy revealed a
decrease in the vacancy-related defect concentration in the high-dose samples, which we interpret as
reflecting an increase in the silicon interstitial concentration. This suggests that silicon interstitials,
arising from the slowly dissolving dislocation loops, may be responsible for the increased
recombination deep within the samples. © 2004 American Institute of Physics.
[DOI: 10.1063/1.1789630]
I. INTRODUCTION
The recombination properties of very low concentrations
of metallic impurities in silicon are of great interest in both
microelectronics and photovoltaics. There are several ap-
proaches of preparing samples with such dilute impurities for
characterization purposes. One possibility is to introduce
contaminants during ingot growth. However, nonuniform
profiles arising from low segregation coefficients, and pre-
cipitation due to low solubility limits, can result in uncertain
outcomes. Similarly, dipping wafers into dilute solutions fol-
lowed by annealing does not usually allow the final concen-
tration in the wafer to be accurately estimated. A more cer-
tain approach is to use ion implantation, which allows very
low and well-controlled concentrations to be introduced. An-
nealing conditions can be chosen to ensure that the final bulk
concentration is uniformly distributed and well below the
solubility limit.
However, a possible unwanted consequence of implanta-
tion is that the primary damage resulting from the ion bom-
bardment may result in secondary defects after annealing.
These may contribute to recombination, thus masking the
effect of the metal impurities. An effective way to study the
impact of any residual secondary damage is to implant a
relatively inert species (such as silicon) into silicon, subject
the wafers to a typical anneal step, and measure the recom-
bination rate or carrier lifetime as a function of dose.
Indeed it is known that relatively high doses of silicon
ions implanted into silicon do result in residual electrically
active centers in the near-surface region after high tempera-
ture annealing (800–900 °C).1,2 However, when implanting
metallic ions for lifetime characterization, this near-surface
region is etched away after annealing. More recent studies3
using carrier lifetime measurements have also shown that
high doses of silicon ions result in residual recombination
centers, even after annealing at 1000 °C for 60 min, and that
these defects penetrate far below the wafer surface.
The purpose of this work is to identify the threshold dose
at which such implantation damage begins to impact on the
bulk carrier lifetime after a typical anneal step. This allows
safe doses to be chosen for studies of specific metallic im-
purities. The nature of the recombination centers that cause
this residual recombination is also explored in more depth.
II. EXPERIMENTAL METHODS
In designing an experiment aimed at characterizing the
impact of unidentified recombination centers, an important
consideration is their relative recombination strength in ei-
ther n- or p-type silicon. Depending on the energy level and
the asymmetry between the capture cross sections for elec-
trons and holes, the recombination activity under low injec-
tion of a given defect may be extremely different in these
two materials. Hence, in this work, where the capture cross
sections and energy levels of the residual defects are not
known a priori, we have analyzed the impact of self-
implantation in both n- and p-type wafers.
Float zone (FZ) phosphorus-doped n-type wafers (1 V
cm) and both FZ (4 V cm) and Czochralski-grown (Cz, 1 V
cm) boron-doped p-type wafers were used. All samples were
of k100l orientation. Prior to implantation, the wafers were
chemically etched and cleaned. Si28 ions were implanted
with an energy of 36 keV in the samples held at s100±7d °C
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and tilted 7° off axis to minimize ion channeling. Doses be-
tween 131011 and 331016 cm−2 were used, requiring im-
plantation times from several seconds to several hours. After
implantation, the wafers were cleaned and annealed in nitro-
gen gas at 900 °C for 60 min. This mimics the annealing
conditions typically used for distributing small concentra-
tions of implanted metal species in silicon wafers.4 Control
wafers of each resistivity and type with no implants were
coannealed with the implanted wafers and subject to exactly
the same cleaning and etching steps. These controls provide
a way of determining the recombination rate due to all pro-
cesses other than those caused by the implant, such as re-
combination at the surfaces, and recombination in the bulk
due to Auger recombination and potential contamination
arising from the annealing, etching, and cleaning steps.
After annealing, it is likely that, at least for the higher
doses, end-of-range dislocation loops will have formed at the
interface of the implanted region and the bulk wafer, as dis-
cussed below. These are regions of high recombination, and
tend to dominate the measured lifetime. Since metal-
implanted samples for lifetime characterization are usually
given a shallow etch after annealing to remove any surface
precipitation, only the residual recombination centers which
penetrate deep into the wafer are of interest here. Conse-
quently, the samples were etched lightly, removing <5 mm
per side (much deeper than the peak implant dose which is
<50 nm).
After another chemical cleaning step, the samples were
subjected to plasma-enhanced chemical-vapor deposition of
70–90 nm thick silicon nitride layers on each surface. This
provides surface passivation to allow carrier lifetime mea-
surements using the quasi-steady-state photoconductance
method.5 With this technique it is possible to measure the
lifetime as a function of excess carrier density Dn, therefore
allowing lifetime comparisons between wafers at the same
value of Dn, which, depending on the magnitude of the life-
time, may not correspond to the same illumination intensity.
The measured quantity is known as an effective lifetime teff
and incorporates the impact of recombination both in the
bulk and at the surfaces.
Deep level transient spectroscopy (DLTS) was per-
formed on the control and selected FZ samples using a modi-
fied lock-in-type apparatus.6 Schottky barrier diodes were
fabricated by thermal evaporation of ,120 nm of Au and
,75 nm of Ti on the n- and p-type samples, respectively.
The diameter of the diodes was 1 mm.
III. DEFECT EVOLUTION DURING ANNEALING
Much is known about the evolution of implantation-
related defects in self-implanted silicon upon high tempera-
ture annealing.7,8 The extent of the primary damage in an
as-implanted sample depends strongly on the ion energy and
the sample temperature during implantation. Higher tempera-
tures result in less damage due to dynamic annealing, which
is significant even near room temperature.9 During subse-
quent high temperature annealing, however, many of the sili-
con interstitials and vacancies which constitute this primary
damage very quickly recombine, either with each other, or at
the surfaces or internal defects.
After this rapid annihilation, the predominant remaining
defects are excess interstitials. These can arise from the
added silicon atoms themselves, and also interstitials that
remain from the primary damage, whose vacancy partners
were annihilated at the surfaces. These interstitials tend to
form {113}-oriented defects during annealing at moderate
temperatures.7 However, these defects are unstable at tem-
peratures above 700 °C. If the implant dose is below a cer-
tain critical value, they rapidly dissolve upon further anneal-
ing, leaving no trace of secondary defects detectable by
DLTS after 15 min at 900 °C.10 However, if the implant dose
is higher than the critical value, these defects evolve into
end-of-range dislocation loops.7,8 These are considerably
more stable than the {113}-oriented defects, and can persist
after annealing at temperatures of up to 1000 °C.3,7
However, at temperatures above 900 °C, these loops also
slowly dissolve, injecting silicon interstitials into the wafer
bulk. Since, in this work, the near-surface loops themselves
are etched away before lifetime measurement, it is the pres-
ence of these injected interstitials deep in the wafers that is
expected to reduce the carrier lifetime. Other defects, and
their dissolution products, are unlikely to be stable enough to
still be present under the anneal conditions used.
The critical dose at which secondary defects (dislocation
loops) persist after annealing at 900 °C has been explored
previously under various implantation conditions. Jones,
Prussin, and Weber found a critical value in the range 1–2
31014 cm−2 for 100 keV Al implants, and also for 50 and
190 keV B implants, with annealing conditions of 900 °C for
30 min.7 They concluded that, at least for energies below 200
keV, the quantity of added atoms is the determining factor in
secondary defect formation, rather than the extent of primary
damage. Hence, the critical dose is effectively independent
of the implantation energy for low energies, and presumably
also of the wafer temperature during implantation. These
conclusions were corroborated by the results of Elliman and
Mitchell,9 who found that the temperature of the wafer dur-
ing implantation did not play a major role in determining the
extent of secondary defects for 540 keV Si implants annealed
at 900 °C for 15 min.
For higher energy implants in the MeV range, however,
the increased extent of primary damage also impacts on the
formation of secondary defects. Schreutelkamp et al.8 found
a critical dose of 531013–131014 cm−2 for 150 keV Si im-
plants after annealing at 900 °C for 15 min, in reasonable
agreement with that of Jones, Prussin, and Weber. However,
they determined a lower value of 2–431013 for 1 MeV
implants. This was confirmed by Kringhøj et al.2,10 who also
found a value of between 3–631013 cm−2 for 1 MeV Si
implants annealed at 900 °C for 15 min and 1–3
31013 cm−2 for 5.6 MeV implants. These results led Schreu-
telkamp to propose that it is the total number of displaced
ions which determine the critical dose for a given energy or
species. Clearly in the case of low-energy Si implants, a
large fraction of these displaced ions may be the added Si
ions themselves. Indeed, simulations by Elliman and
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Mitchell9 showed that for 540 keV Si implants, the im-
planted interstitial ions outnumbered the displaced Si atoms
by approximately 5 to 1 before annealing.
The important conclusion from these results is that, for
the low-energy implants used here (36 keV), the critical dose
for secondary defect formation should be in the range of 5
31013–231014 cm−2. In addition, this critical dose should
be almost independent of implantation temperature and
variations in energy up to <500 keV, at least for light spe-
cies.
IV. RESULTS AND DISCUSSION
Figure 1 shows the measured effective lifetimes at an
excess carrier density of Dn=131015 cm−3 as a function of
implant dose, after annealing at 900 °C. It is clear that for
doses below 1013 cm−2, the implanted wafers are, within er-
ror, comparable to the control wafers. Hence, there is no
additional recombination in these samples, in agreement with
DLTS studies on wafers with implants below the critical dose
and annealed at 900 °C.2 Note that this threshold value is
valid for both the n- and p-type wafers, and allows us to
conclude that doses below this value are certainly safe to use
for preparing metal implanted wafers for lifetime character-
ization.
However, for doses at and above 131014 cm−2, the mea-
sured carrier lifetime begins to drop. Also shown in Fig. 1 is
a linear defect model fitted to the p-type data. This simple
model assumes that the increase in recombination center
density due to secondary defects increases linearly with the
implant dose. In this model, the measured lifetime of the
control wafers represents the recombination rate due to all
processes other than those caused by implantation. The total
recombination rate, which is inversely proportional to the
measured effective lifetime, is the sum of the rates due to the
implanted defects and the “other” channels:
1
teff
=
1
timplant
+
1
tother
. s1d
Figure 1 shows that this model does indeed provide a
reasonable fit for the measured data. The fit is also reason-
able for the n-type data after adjusting only the value of
tother, indicating that the recombination centers introduced
have a similar impact on p- and n-type silicon.
The threshold dose found here for increased recombina-
tion corresponds very well with the critical dose discussed
above of 531013–231014 cm−2 for dislocation loop forma-
tion. It seems likely then that, in our samples, the slowly
dissolving dislocation loops are responsible for this increased
recombination.
From the perspective of determining safe doses for metal
implants, it is important to consider the origin of the silicon
interstitials which form the loops. It may be that many of
them are simply those Si atoms added by the implantation
process, as discussed above. In this case, they simply replace
the metallic ions normally implanted, and thus cause an un-
derestimation of the maximum safe dose. It is only the re-
combination due to other interstitials propagated from the
implanted region into the bulk that will restrict the safe dose
range. However, it is difficult to distinguish between im-
planted and displaced interstitials, so it suffices to say that
the threshold dose determined here is a conservative lower
limit.
A. Presence of silicon interstitials
The presence of silicon interstitials can be detected indi-
rectly with the aid of DLTS. Figure 2 shows DLTS spectra
for two n-type samples: the control and the sample implanted
with 1015 cm−2 Si ions. Recall that these samples were
etched after annealing, and so the DLTS spectra probe trap-
ping centers well below the original implanted region. The
peak at 83 K is identified as the vacancy-oxygen center,11
and is a measure of the vacancy concentration. Despite the
relatively low oxygen content of float-zone silicon (around
1015–1016 cm−3) compared to Czochralski-grown silicon,
there is still ample oxygen for this defect to form in detect-
able concentrations, as has previously been observed.12 From
the peak height in Fig. 2, the vacancy-oxygen density is es-
timated to be in the order of 1012 cm−3 in the control sample.
Upon implanting and annealing, this peak decreases in mag-
nitude significantly. This reduction in vacancy concentration
can be attributed to an increase in the silicon interstitial con-
centration, arising from the dissolving dislocation loops,
FIG. 1. Effective lifetime measured at Dn=1015 cm−3 as a function of Si
implant dose for n- and p-type wafers, after annealing at 900 °C for 60 min
and etching 5 µm from each surface. The solid line represents the linear
defect model.
FIG. 2. DLTS spectra for two n-type samples: an unimplanted control wafer,
and a Si implanted wafer with a dose of 1015 cm−2. Both samples were
annealed at 900 °C for 60 min.
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which annihilate vacancies during annealing. Clearly these
vacancy-oxygen complexes cannot be the source of the in-
creased recombination in the implanted samples, since their
concentration decreases with dose. However, they do indi-
cate that the silicon interstitial concentration is increased in
the implanted samples, as is expected from the creation of
dislocation loops for the higher doses. These excess silicon
interstitials may form some other complexes, for example,
with oxygen or carbon, which result in greater recombina-
tion, resulting in the decrease in lifetime seen in Fig. 1.
Majority carrier DLTS spectra on the n-type samples
only reveal levels in the upper half of the band gap that
effectively trap majority carriers or electrons. Corresponding
spectra on p-type samples up to 280 K revealed no discern-
ible majority carrier (hole) traps in the lower half of the band
gap for an implant dose of 1015 cm−2, or in the control
sample. Hence, if majority carrier traps due to the excess
silicon interstitials are present in these samples, they appear
to be below the sensitivity limit of DLTS. Their chemical
make up therefore remains unclear.
Note, however, that Fig. 1 also shows results for
B-doped Cz wafers. These wafers contain at least one order
of magnitude more interstitial oxygen than the FZ samples,
and yet they yield similar lifetimes to the FZ wafers as a
function of dose. This tends to indicate that interstitial oxy-
gen is not a key component of the recombination centers
generated during annealing.
B. Presence of interstitial iron
Although the identity of the interstitial-related recombi-
nation centers is not clear from the DLTS spectra, it turns out
that there is another source of recombination related to the
implantation that can be identified. Interstitial Fe sFeid in
p-type silicon forms pairs with the dopant boron atoms (FeB
pairs). There exists a reliable technique for identifying and
determining the concentration of Fei by measuring the life-
time before and after breaking the FeB pairs with strong
illumination or light soaking.13,14 If Fei exists, the lifetime
increases after pair breaking at excess carrier concentrations
above <1014 cm−3, and decreases below this point. This re-
sults in lifetime curves that crossover at this characteristic
point, allowing unambiguous identification of Fei in boron-
doped wafers. Also, by measuring the change in lifetime at a
given excess carrier density, the concentration of Fe can be
determined from the difference in inverse lifetimes in con-
junction with a calibration constant determined by the dop-
ing level and the carrier density measured.14 For the 4 V cm
B-doped wafers used here, at an injection level of 1
31015 cm−3, this constant is −7.231013 ms cm−3.
Figure 3 shows injection-dependent lifetime curves be-
fore and after light soaking for 1 min with white light of
approximately one sun intensity s100 mW cm−2d. Two
samples are shown, one which was implanted with 1016 cm−2
of Si ions and another that was not implanted, but contami-
nated with Fe by high temperature annealing (1000 °C) in an
unclean furnace. Both samples reveal an increase in lifetime
at high carrier concentrations, and a crossover point near
1014 cm−3. This strongly suggests the presence of Fei in both
samples. Interstitial Fe produces a center at 0.38 eV above
the valence band, but is not visible in the p-type DLTS spec-
tra because it is paired with the boron ions to form FeB pairs,
which produce a level in the upper half of the band gap.15
From the change in lifetime after light soaking, the con-
centration of interstitial Fe, fFeig can be determined. Figure 4
shows how fFeig (in units cm−3) increases as a function of the
Si implant dose (units cm−2). The straight line represents a
linear function with a constant term of 1.531011 cm−3. The
constant term corresponds to Fe contamination present even
without implantation, and may be caused by furnace con-
tamination or the presence of Fe in the starting material.
Nevertheless, for Si doses above 1015 cm−3, the Fe concen-
tration increases linearly with the Si dose, suggesting con-
tamination in the ion beam. From the linear term in the fit in
Fig. 4, and knowing the wafer thickness to be 0.026 cm, it
seems that <4 ppm of the ion beam are in fact Fe ions.
An important question is how much the presence of
parasitic Fe affects the measured lifetimes in Fig. 1. It is
conceivable in fact that the linear dependence in Fig. 1 arises
solely because of the presence of Fei, and is not attributable
to the presence of Si interstitials at all! The change in life-
time after light soaking for the silicon implanted sample
gives an Fei concentration of 1.2531012 cm−3, while the Fe-
FIG. 3. Injection-dependent lifetime measurements for a Si implanted
p-type sample (1016 cm−2 dose) and an unimplanted but Fe-contaminated
p-type sample. Curves are shown before and after light soaking for each
sample.
FIG. 4. Bulk Fe concentration as a function of Si implant dose. The solid
line shows a linear fit to the data.
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contaminated but unimplanted sample yields a value of 5.5
31012 cm−3. From the known energy level and capture cross
sections14 of Fei we may calculate what the lifetime would
be at this carrier density if only Fei were present. This yields
values of 260 and 60 µs for these two samples, respectively.
For the Fe-contaminated sample, the lifetime due to Fei alone
is very close to the measured lifetime (65 µs), revealing that
this sample is in fact completely dominated by the presence
of Fei.
This is not the case for the Si-implanted sample. Using
an analog of Eq. (1), it is possible to determine the value of
the lifetime in this sample due to all other recombination
channels except Fei. This gives a value of 38 µs. Alterna-
tively stated, if the relatively small amount of Fei in the
silicon implanted sample were somehow removed, the mea-
sured (light-soaked) lifetime would only increase from 33 to
38 µs. This indicates that the presence of Fei is only respon-
sible for a small fraction of the observed reduction in life-
time after implantation and annealing.
Note that this conclusion is only valid for lifetimes mea-
sured after light soaking. Accordingly, all of the lifetime
measurements in Fig. 1 are recorded after light soaking for 1
min. The important conclusion is that, in this case, the mea-
sured lifetimes are dominated by recombination centers other
than Fe. These remaining recombination centers may be re-
lated to the presence of the excess silicon interstitials.
V. CONCLUSIONS
Lifetime measurements of self-ion implanted silicon wa-
fers have revealed that there is negligible additional recom-
bination in the wafer bulk after annealing at 900 °C for 60
min for implant doses below 1013 cm−2. This indicates the
range of doses which are safe to use for preparing metal-
implanted samples for lifetime characterization. This thresh-
old value corresponds to the critical dose known to cause the
formation of relatively stable dislocation loops during high
temperature annealing. It seems that the slow dissolution of
these loops results in the injection of silicon interstitials into
the wafer bulk, as detected by DLTS. In samples with doses
above the threshold value, the recombination center density
increases linearly with implant dose, in conjunction with the
extent of loop formation. A small proportion of this increased
recombination is due to parasitic Fe contamination in the ion
beam. The majority, however, appears to be related to the
presence of the excess silicon interstitials in the wafer bulk.
Since at least some of the excess interstitials are likely to
arise from the implanted ions themselves, rather than atoms
they displace, the threshold of 1013 cm−2 is in fact a conser-
vative lower limit on which doses are safe to use for other
species.
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